Sacubitril/valsartan inhibits ox‑LDL‑induced MALAT1 expression, inflammation and apoptosis by suppressing the TLR4/NF‑κB signaling pathway in HUVECs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sacubitril/valsartan inhibits ox‑LDL‑induced MALAT1 expression, inflammation and apoptosis by suppressing the TLR4/NF‑κB signaling pathway in HUVECs

Published:2021-03-26 Issue:6 Volume:23 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Bai Wenlou¹,Huo Tiantian²,Chen Xuefeng³,Song Xuelian³,Meng Cunliang³,Dang Yi³,Rong Chunli³,Dou Liwen³,Qi Xiaoyong³

Affiliation:

1. Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China

2. Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China

3. Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice;Journal of Atherosclerosis and Thrombosis;2024-09-01

2. Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives;Current Medical Science;2023-12-07

3. Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway;Pulmonary Pharmacology & Therapeutics;2023-10

4. Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects;Biomolecules;2023-05-17

5. The history and mystery of sacubitril/valsartan: From clinical trial to the real world;Frontiers in Cardiovascular Medicine;2023-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3